Request Deal Involvement

Bain Capital Life Sciences led a $120m Series C round in Angitia Biopharmaceuticals.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Solebury Strategic Communications

pr advisors

Solebury Strategic Communications

Cooley

legal advisors

Cooley

or

Principals

JANUS HENDERSON INVESTORS

bidder

JANUS HENDERSON INVESTORS

ORBIMED ADVISORS LLC

bidder

ORBIMED ADVISORS LLC

ANGITIA BIOPHARMACEUTICALS

target

ANGITIA BIOPHARMACEUTICALS

BAIN CAPITAL LIFE SCIENCES

bidder

BAIN CAPITAL LIFE SCIENCES

YONGHUA CAPITAL

bidder

YONGHUA CAPITAL

ELIKON VENTURE

bidder

ELIKON VENTURE

3H HEALTH INVESTMENT

bidder

3H HEALTH INVESTMENT

LEGEND CAPITAL

bidder

LEGEND CAPITAL

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Bain Capital Life Sciences led a $120m Series C round in Angitia Biopharmaceuticals.